Estimation Of Salivary Superoxide Dismutase Level In Oral Submucous Fibrosis: A Clinical And Biochemical Study
DOI:
https://doi.org/10.51985/JBUMDC2018106Keywords:
Free radicals, Lipid peroxidation, mouth opening, oral submucosal fibrosis (OSMF), salivary, Superoxide dismutase (SOD).Abstract
Objective: The objective of the study was to compare the salivary Superoxide dismutase (mU/L) level among stage one patients of Oral sub mucous fibrosis and healthy controls. Study Design and Setting: It was a comparative cross sectional study design conducted at Outpatient clinic of Dental Department at Ziauddin University Hospital from January 2012 till December 2013. Methodology: Eighty histo-pathologically confirmed patients of clinical stage one Oral Sub mucosal fibrosis (OSMF) and eighty healthy controls were matched for age and gender to recruit in the study. Socio demographic information (i.e. age, gender, ethnicity, education and occupation), oral health status, measurement of mouth opening (mm) and Superoxide dismutase (mU/L) were recorded. The study was conducted after the approval granted from the ethical review committee of Ziauddin University Hospital. Data was entered and analyzed using SPSS version 21 (IBM). Result: The standard mean (+/-SD) of Superoxide dismutase (mU/L) in both groups was 4.99 (+/-2.18). The mean of Superoxide dismutase (mU/L) in confirmed cases of oral sub mucosal fibrosis was 3.02 (+/-0.44) which was significantly lower as compared to the control group which was 6.96(+/-1.24) and the calculated p value was 0.001.The strong positive correlation was identified in mouth opening (mm) and superoxide dismutase (0.842). Conclusion: It was concluded that the levels of salivary superoxide dismutase was significantly lower in the sample of OSMF and lower levels of superoxide dismutase (mU/L) was the indication of decrease in mouth opening among the cases of OSMF. Therefore, salivary superoxide dismutase can be used as a biomarker for the early detection as well as successful treatment of OSMF.
References
Tilakaratne WM, Ekanayaka RP, Warnakulasuriya S. Oral submucous fibrosis: a historical perspective and a review on etiology and pathogenesis. Oral Surg Oral Med Oral Pathol Oral Radiol 2016;122(2):178-91.
Tanwir F, Akhlaq H. Oral submucous fibrosis: A chronic deliberating disease of oral cavity. Iran J Pathol 2011;6(4):165-72.
Tak J, Gupta N, Bali R. Oral submucous fibrosis: A review article on etiopathogenesis. Kathmandu Univ Med J 2014;12(2):153-6.
Byakodi R, Byakodi S, Hiremath S, Byakodi J, Adaki S, Marathe K, et al. Oral cancer in India: An epidemiologic and clinical review. J Community Health 2012;37(2):316-319.
Epstein JB, Gorsky M, Cabay RJ, Day T, Gonsalves W. Screening for and diagnosis of oral premalignant lesions and oropharyngeal squamous cell carcinoma: Role of primary care physicians. Can Fam Phys 2008;54(6):870-5.
Pindborg JJ, Sirsat SM. Oral submucous fibrosis. Oral Surg Oral Med Oral Pathol 1966;22(6):764-79.
Mehta FS, Pindborg JJ, Gupta PC, Daftary DK, Odont. Epidemiologic and histologic study of oral cancer and leukoplakia among 50,915 villagers in India. Cancer 1969;24(4):832-49.
Alamgir M, Jamal Q, Mirza T, Jafarey NA. Genetics of oral cancer in relationship to carcinogen-metabolizing genes. Pak J of Otolaryng. 2010;26:81-4.
Di Dalmazi G, Hirshberg J, Lyle D, Freij JB, Caturegli P. Reactive oxygen species in organ-specific autoimmunity. Autoimmun Highlights 2016;7(1).
Shetty S, Babu S, Kumari S, Shetty P, Hegde S, Castelino R. Status of salivary lipid peroxidation in oral cancer and precancer. Indian J Med PaediatrOncol 2014;35(2):156-8.
Menvielle-Bourg FJ. Superoxide dismutase (SOD), the powerful natural antioxidant, now available orally. Phytotherapie 2005;3(3):118-21.
Signorella S, Palopoli C, Ledesma G. Rationally designed mimics of antioxidant manganoenzymes: Role of structural features in the quest for catalysts with catalase and superoxide dismutase activity. CoordChem Rev 2018;365:75-102.
Griess B, Tom E, Domann F, Teoh-Fitzgerald M. Extracellular superoxide dismutase and its role in cancer. Free RadicBiol Med 2017;112:464-79.
Romo MR. Superoxide Dismutase: A therapeutic candidate for oxidative stress. An R Acad Farm 2015;81(1):25-36.
Carillon J, Rouanet J-, Cristol J-, Brion R. Superoxide dismutase administration, a potential therapy against oxidative stress related diseases: Several routes of supplementation and proposal of an original mechanism of action. Pharm Res 2013;30(11):2718-28.
Metkari SB, Tupkari JV, Barpande SR. An estimation of serum malondialdehyde, superoxide dismutase and vitamin A in oral submucous fibrosis and its clinicopathologic correlation. J Oral MaxillofacPathol2007;11(1):23-7.
Gurudath S, Ganapathy KS, Sujatha D, Pai A, Ballal S, Ml A. Estimation of superoxide dismutase and glutathione peroxidase in oral submucous fibrosis, oral leukoplakia and oral cancer - a comparative study. Asian Pac J Cancer Preven 2012;13(9):4409-12.
Uikey AK, Hazarey VK, Vaidhya SM. Estimation of serum antioxidant enzymes superoxide dismutase and glutathione peroxidase in oral submucous fibrosis: A biochemical study. J Oral MaxillofacPathol2003;7(2):44-8.
Bale R, Kattappagari KK, Vidya D, Vuddandi S, Gummalla C, Baddam VRR. Oral submucous fibrosis: A quantitative assessment of serum malondialdehyde, superoxide dismutase and correlation with clinical staging. J Oral MaxillofacPathol 2017;21(1):41-5.
Bari S, Metgud R, Vyas Z, Tak A. An update on studies on etiological factors, disease progression, and malignant transformation in oral submucous fibrosis. J Cancer Res Ther 2017;13(3):399-405.
Patel J, Shah F, Joshi G, Patel P. Clinical significance of inflammatory mediators in the pathogenesis of oral cancer. J Cancer Res Ther 2016;12(2):447-57.
Sadaksharam J. Significance of serum nitric oxide and superoxide dismutase in oral submucous fibrosis and squamous cell carcinoma: A comparative study. ContempClin Dent 2018;9(2):283-288.
AvinashTejasvi ML, Bangi BB, Geetha P, AnulekhaAvinash CK, Chittaranjan B, Bhayya H, et al. Estimation of serum superoxide dismutase and serum malondialdehyde in oral submucous fibrosis: A clinical and biochemical study. J Cancer Res Ther 2014;10(3):722-725.
Emori Y, Mizushima T, Matsumura N, Ochi K, Tanioka H, Shirahige A, et al. Camostat, an oral trypsin inhibitor, reduces pancreatic fibrosis induced by repeated administration of a superoxide dismutase inhibitor in rats. J GastroenterolHepatol 2005;20(6):895-899.
Kärkkäinen J, Saimanen I, Selander T, Aspinen S, Harju J, Juvonen P, et al. Gallstone patients with enhanced oxidative stress biomarker superoxide dismutase (SOD1) plasma levels have significantly lower number of postoperative analgesic oxycodone doses: A prospective study with special reference to cancer patients. Anticancer Res 2018;38(6):3573-78.
Park S-, Nair PMG, Choi J. Characterization and expression of superoxide dismutase genes in Chironomusriparius (Diptera, Chironomidae) larvae as a potential biomarker of ecotoxicity. Comp BiochemPhysiol C ToxicolPharmacol 2012;156(3-4):187-194.
Choi J, Roche H, Caquet T. Characterization of superoxide dismutase activity in Chironomusriparius Mg. (Diptera, Chironomidae) larvae - A potential biomarker. Comp BiochemPhysiol C PharmacolToxicolEndocrinol 1999;124(1):73-81.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2019 Humera Akhlaq, Muhammad Owais Ismail, Muhammad Abdul Samad
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Journal of Bahria University Medical & Dental College is an open access journal and is licensed under CC BY-NC 4.0. which permits unrestricted non commercial use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc/4.0 
